Shock




Common misconceptions and mistakes




  • •

    Overresuscitating patients with septic shock


  • •

    Underresuscitating patients with hemorrhagic shock


  • •

    Underresuscitating severe pancreatitis


  • •

    Attempting to initially differentiate isolated right-ventricular (RV) cardiogenic shock from left-ventricular (LV) cardiogenic shock by echocardiogram rather than by chest x-ray (looking for pulmonary edema/pleural effusion)


  • •

    Missing dependent edema (eg, sacral) during the physical examination


  • •

    Failing to consider hemorrhage in inpatients (not admitted for bleeding) who develop shock, instead presuming sepsis





Shock




  • •

    Pathologically low blood pressure (BP) resulting in end organ hypoperfusion


  • •

    Occurs when the normal homeostatic mechanisms protecting organ perfusion (ie, increased sympathetic activity aimed at increasing cardiac output [CO] and systemic vascular resistance [SVR]) fail, leading to systemic tissue hypoxia and organ injury/dysfunction (specifically):



    • •

      Acute kidney injury (often acute tubular necrosis with oliguria)


    • •

      Shock liver (asymptomatic transaminitis or increased international normalized ratio [INR])


    • •

      Decreased mental status (lethargy to obtundation)


    • •

      Lactic acidosis from underperfused skeletal muscle and intestine



  • •

    If not reversed, shock will cause death by pulseless electrical activity (PEA) arrest secondary to overwhelming lactic acidosis


  • •

    Shock is diagnosed when end organ hypoperfusion is proven in the setting of low BP



    • •

      Hypoperfusion is evidenced by organ failure and the presence of an elevated serum lactate



  • •

    Tachycardia is anticipated in all causes of shock not directly related to bradycardia and/or heart block



    • •

      Individuals with baseline conduction system disease may not mount an appropriate tachycardia



      • •

        Shock with “relative bradycardia” may require inotropic/chronotropic support




  • •

    There are four distinct pathophysiologic types of shock, with six cardiogenic subtypes ( Table 18.1 ):



    • •

      Hypovolemic shock



      • •

        Hypovolemic shock is caused by one of the following:



        • •

          Acute blood loss (hemorrhage)


        • •

          Volume depletion, as seen with gastrointestinal (GI) and renal NaCl loss


        • •

          Third-spacing physiology, as seen in severe pancreatitis or after a large intraabdominal surgery



      • •

        Leads to a decreased central venous pressure (CVP), right ventricular end-diastolic pressure (RVEDP), and left ventricular end-diastolic pressure (LVEDP), reducing stroke volume and thus CO


      • •

        Decreased CO triggers an increase in sympathetic activity, leading to tachycardia and a maximally increased SVR (renin–angiotensin system activation)



    • •

      Distributive shock



      • •

        Distributive shock is caused by one of the following:



        • •

          Sepsis (cytokine mediated)


        • •

          Anaphylaxis, as seen in allergic-mediated diffuse mast cell degranulation and histamine release


        • •

          Adrenal crisis, as seen in adrenal insufficiency with provocative stress (eg, bleeding)


        • •

          Severe pancreatitis (cytokine mediated)


        • •

          Neurogenic Shock (central nervous system [CNS] mediated, as in spinal cord injury)



      • •

        Leads to inappropriate arteriolar vasodilation and increased capillary permeability (capillary leak), which decreases SVR and effective circulating volume, causing hypotension


      • •

        Hypotension triggers an increase in sympathetic activity, leading to tachycardia and an increased CO



        • •

          Importantly, distributive shock from sepsis often causes concomitant myocardial depression, decreasing CO




    • •

      LV cardiogenic shock (HFpEF, HFrEF, and mechanical failure)



      • •

        From LV failure, as seen in acute systolic dysfunction from ischemia, acute diastolic dysfunction from arrhythmia or hypoxemia, or mechanical failure (ie, papillary muscle rupture)


      • •

        Leads to a decreased CO and an increase in LVEDP, mean pulmonary arterial pressure (mPAP), RVEDP, and CVP


      • •

        Decreased CO triggers an increase in sympathetic activity, leading to tachycardia and a maximally increased SVR



    • •

      RV cardiogenic shock (with PH, without PH, and mechanical failure)



      • •

        From isolated RV failure (systolic dysfunction), occurring with pulmonary hypertension (eg, pulmonary embolism), without pulmonary hypertension (eg, RV infarct), or with mechanical failure as in pericardial effusion with tamponade


      • •

        Decreased RV stroke volume causes a decrease in RV CO, which leaves the left ventricle underfilled leading to an increased RVEDP and CVP and a decreased LVEDP, LV stroke volume, and LV CO


      • •

        The decreased CO triggers an increase in sympathetic activity, leading to tachycardia (unless the conduction system is injured as in inferior wall myocardial infarction with RV infarct) and a maximally increased SVR




    Table 18.1

    Pathophysiologic Types of Shock

































































    Type of Shock and Common Causes Anticipated Hemodynamics
    Red = primary insult
    Black = direct consequence
    Blue = compensatory neurohormonal response
    Anticipated Edema Anticipated
    Echocardiographic Finding
    Hypovolemic


    • •

      Blood loss (GI, spontaneous, postprocedure)


    • •

      Fluid loss (GI/renal)


    • •

      Third spacing


    • •

      Severe pancreatitis


    • •

      Postoperative abdominal surgery

    ↓CVP, ↓RVEDP, ↓PAP, ↓ LVEDP, ↓ CO, ↑SVR No edema ↑RV EF, no PH, nl LA, ↑LV EF
    Distributive:


    • •

      Sepsis without myocardial depression

    ↓CVP, ↓ RVEDP, ↓ PAP, ↓ LVEDP, ↑CO, ↓SVR No edema ↑RV EF, No PH, nl LA, ↑LV EF


    • •

      Sepsis with myocardial depression

    ↑CVP, ↑ RVEDP, ↑ PAP, ↑ LVEDP, ↓CO, ↓SVR Pulmonary edema
    Peripheral edema
    ↓RV EF, ↑PAS, ↑ LA, ↓LV EF


    • •

      Severe pancreatitis with necrosis


    • •

      Anaphylaxis


    • •

      Adrenal insufficiency


    • •

      Severe acidosis pH < 7.2

    ↓CVP, ↓ RVEDP, ↓ PAP, ↓ LVEDP, ↑ CO, ↓SVR No edema ↑RV EF, No PH, nl LA, ↑LV EF
    LV cardiogenic (systolic dysfunction):


    • •

      Ischemia, EtOH, viral, tachyarrhythmia (subacute), Takotsubo, idiopathic


    • •

      Long standing:


    • •

      Aortic or mitral regurgitation, aortic stenosis, HTN

    ↑CVP, ↑RVEDP, ↑PAP, ↑ LVEDP, ↓ CO, ↑SVR Pulmonary edema
    Peripheral edema *
    ↓RV EF, ↑PAS, ↑ LA, ↓LV EF
    LV cardiogenic (diastolic dysfunction):


    • •

      Tachyarrhythmia (acute)


    • •

      Hypoxemia (PaO 2 < 60 mm Hg)


    • •

      Volume overload

    ↑CVP, ↑RVEDP, ↑PAP, ↑ LVEDP, ↓ CO, ↑SVR Pulmonary edema
    Peripheral edema *
    ↓RV EF, ↑PAS, ↑ LA, ↑LV EF
    LV cardiogenic mechanical failure:


    • •

      Mitral regurgitation (acute)


    • •

      Aortic regurgitation (acute)


    • •

      Outflow tract obstruction


    • •

      Aortic stenosis


    • •

      HOCM

    ↑CVP, ↑RVEDP, ↑PAP, ↑ LVEDP, ↓ CO, ↑SVR Pulmonary edema
    Peripheral edema *
    Mitral regurgitation
    Aortic regurgitation
    Aortic stenosis
    HOCM
    RV cardiogenic, with pulmonary HTN:


    • •

      Acute PE


    • •

      CTEPH


    • •

      IPAH

    ↑CVP, ↑RVEDP, ↑PAP, ↓LVEDP, ↓ CO, ↑SVR Peripheral edema * ↓RV EF, ↑PAS, nl LA, ↑LV EF



    • •

      Mitral stenosis

    ↑CVP, ↑RVEDP, ↑PAP, ↓LVEDP, ↓ CO, ↑SVR
    (Note: PCWP elevated despite nl LVEDP because of increased LAP and PVP)
    Pulmonary edema
    Peripheral edema *
    Mitral stenosis
    RV cardiogenic, without pulmonary HTN:


    • •

      RV infarct

    ↑CVP, ↑RVEDP, ↓ PAP, ↓ LVEDP, ↓ CO, ↑SVR Peripheral edema * ↓RV EF, no PH, nl LA, ↑LV EF
    RV cardiogenic, without pulmonary HTN mechanical failure:


    • •

      Pericardial effusion with tamponade


    • •

      Constrictive pericarditis


    • •

      Restrictive cardiomyopathy

    ↑CVP, ↑RVEDP, ↓ PAP, ↓ LVEDP, ↓ CO, ↑SVR Peripheral edema * Echo signs consistent with:


    • •

      Tamponade physiology


    • •

      Constrictive pericarditis


    • •

      Restrictive cardiomyopathy


    CO , Cardiac output; CTEPH , chronic thromboembolis pulmonary hypertension; CVP, central venous pressure; EtOH , ethyl acohol; GI , gastrointestinal; HOCM , hypertrophic obstructive cardiomyopathy; HTN , hypertension; IPAH , idiopathic pulmonary arterial hypertension; LAP, left atrial pressure; LVEDP, left ventricular end diastolic pressure; PAP, pulmonary artery pressure; PAS , pulmonary artery systolic; PCWP , pulmonary capillary wedge pressure; PE , pulmonary embolism; PVP, pulmonary venous pressure; RVEDP, right ventricular end-diastolic pressure; SVR, systemic vascular resistance.

    ↑LV EF = Normal or high LV ejection fraction

    ↓LV EF = Systolic dysfunction

    ↑RV EF = Normal or hyperdynamic RV function

    ↓RV EF = Decreased or hypodynamic RV function and/or RV or RA dilation

    ¥ Pulmonary edema = Interstitial edema, alveolar edema, or pleural effusion

    * In cases of acute LV and RV cardiogenic shock, peripheral edema takes hours to become appreciable even though right-sided pressures increase instantly.




Initial Evaluation




  • •

    History should focus on screening for symptoms of:



    • •

      Infection (eg, fever, chills, cough, dysuria, abdominal or extremity pain)


    • •

      Bleeding (eg, hematemesis/coffee-ground emesis, bright-red blood per rectum, melena)


    • •

      Left-sided heart failure (eg, paroxysmal nocturnal dyspnea, orthopnea, increased edema, weight gain)


    • •

      Exertional syncope, which is seen in both:



      • •

        Isolated right-sided heart failure (eg, pulmonary arterial hypertension [PAH])


      • •

        Left-sided heart failure from outflow tract obstruction (ie, hypertrophic obstructive cardiomyopathy [HOCM])




  • •

    Physical examination should focus on:



    • •

      Temperature



      • •

        Fever and hypotension equal sepsis until proven otherwise



    • •

      Heart rate



      • •

        Anticipate sinus tachycardia (relative bradycardia implies conduction system disease or atrioventricular [AV] nodal blockade)



    • •

      Blood pressure (BP)



      • •

        Interpret relative to baseline BP:



        • •

          Patients with long-standing, poorly controlled hypertension may experience end organ hypoperfusion despite an mean arterial pressure (MAP) ≥ 60 mm Hg and/or an systolic blood pressure (SBP) ≥ 90 mm Hg




    • •

      Mental status



      • •

        Anticipate delirium and/or globally decreased sensorium with septic shock secondary to poor cerebral perfusion and cytokines


      • •

        Anticipate globally decreased sensorium in cardiogenic shock secondary to poor cerebral perfusion from decreased cardiac output


      • •

        Individuals with hemorrhagic shock tend to have a normal mental status despite significant hypotension because cerebral perfusion is maintained by cerebral autoregulation



    • •

      Ability to lie flat comfortably (unusual in LV mediated cardiogenic shock)


    • •

      Presence or absence of:



      • •

        Oxygen requirement (suggesting LHF, pneumonia, or acute respiratory distress syndrom [ARDS])


      • •

        Heart murmur suggesting valve failure, or a prominent S2 suggesting (pulmonary hypertension [PH]) and/or an S3 suggesting (left-ventricular [LV] dysfunction)


      • •

        Thoracic edema (ie, crackles, decreased breath sounds with dullness) suggesting LHF


      • •

        Peripheral edema suggesting HF



    • •

      Markers of cutaneous perfusion may reflect the underlying systemic vascular resistance (ie, poor perfusion implies a high SVR shock state and good perfusion implies a distributive shock state)



      • •

        Skin color (hyperemic or pale)


      • •

        Skin temperature (warm or cool)




  • •

    Initial diagnostic labs and imaging include:



    • •

      Complete blood count (CBC) looking for anemia and/or leukocytosis


    • •

      Coagulation studies looking for coagulopathy


    • •

      Chemistries with renal and liver indices and an anion gap calculation


    • •

      Lactate


    • •

      Arterial blood gas (ABG) to check the pH, screen for respiratory failure, and assess gas exchange



      • •

        A pH < 7.25 (but typically < 7.20) may cause a low SVR state, in and of itself, as intrinsic (and extrinsic) pressors fail in the acidotic milieu


      • •

        Shunt physiology (ie, PaO 2 < 200 mm Hg on 100%) is worrisome for either cardiogenic or noncardiogenic pulmonary edema



    • •

      Troponin test looking for evidence of LV or RV ischemia


    • •

      ECG looking for ischemia and/or right heart strain (ie, S I, Q III, flipped T in III)


    • •

      Chest x-ray looking for thoracic fluid and/or pneumonia


    • •

      Urinalysis looking for infection and/or casts consistent with acute tubular necrosis (ATN)


    • •

      Bedside echocardiogram looking at global RV and LV size and function, and screening for a pericardial effusion




Differentiating the Types of Shock ( Fig. 18.1 )




  • •

    First differentiate cardiogenic from noncardiogenic etiologies by looking for the presence or absence of any peripheral and/or thoracic edema (ie, alveolar edema, pulmonary interstitial edema, or pleural effusion)



    • •

      Patients in hypovolemic or distributive shock will not have any edema at presentation (unless they had preexisting heart failure and volume overload)


    • •

      Patients with LV -mediated cardiogenic shock will have pulmonary edema and peripheral edema



      • •

        Shock from acute LV failure leads to “flash pulmonary edema,” a sudden rise in LVEDP, causing dyspnea and gas exchange abnormalities (ie, hypoxemia) with radiographic evidence of pulmonary edema, often without obvious peripheral edema at presentation


      • •

        Peripheral edema and pleural effusion may take hours to become appreciable (despite an immediate elevation in pulmonary artery pressure [PAP], RVEDP, RA and CVP)



    • •

      Patients with RV -mediated cardiogenic shock (isolated right heart failure) will have peripheral edema only (no pulmonary edema)



      • •

        Shock from acute RV failure may present without obvious peripheral edema which may take hours to become appreciable (despite an immediate elevation in RVEDP and CVP)




  • •

    Next asses cutaneous perfusion (ie, warm vs cool extremities)



    • •

      Distributive shock (a low SVR state) produces warm , cutaneously well-perfused extremities


    • •

      Both hypovolemic and cardiogenic shock (high SVR states) produce cool, cutaneously poorly perfused extremities



  • •

    Then obtain a cardiac echocardiogram aimed at globally assessing RV and LV function and right- and left-sided pressures (eg, atrial chamber size and estimated pulmonary artery systolic [PAS] pressure) while ruling out tamponade and acute valve failure:



    • •

      The echocardiogram is key in differentiating cardiogenic shock from hypovolemic or distributive shock


    • •

      Distributive and hypovolemic shock states cause the right and left ventricles to be underfilled, appearing on an echocardiogram as hyperdynamic (ie, with an increased ejection fraction)


    • •

      LV-mediated cardiogenic shock has two possible echocardiographic findings:



      • •

        Decreased systolic function, a.k.a. HFrEF


      • •

        Preserved systolic function, a.k.a. HFpEF



        • •

          Both HFpEF and HFrEF will cause an increase in LA pressure and mPAP



          • •

            However, echocardiographic evidence of LA enlargement and/or mPAP elevation are not guaranteed



            • •

              The left atrium may not always enlarge under pressure, and echocardiography may underestimate (or miss) pulmonary hypertension






    • •

      RV-mediated cardiogenic shock from mechanical failure as a result of pericardial effusion with tamponade physiology or LV-mediated cardiogenic shock as a result of aortic or mitral valve failure, can also be readily identified by echocardiogram


    • •

      RV-mediated cardiogenic shock (isolated right heart failure) shares the same core echocardiographic findings as LV-mediated cardiogenic shock caused by HFpEF—namely RV dysfunction with preserved LV function



      • •

        Therefore isolated RV-mediated cardiogenic shock is differentiated from LV-mediated cardiogenic shock due to HFpEF by the presence or absence of pulmonary edema ( not echocardiographic findings)



        • •

          That said, left atrial enlargement (without mitral valve disease) strongly supports a HFpEF etiology





  • •

    Mixed physiology shock



    • •

      Distributive shock with concomitant heart failure occurs relatively commonly, as infection and sepsis can decompensate preexisting heart failure in addition to causing myocardial depression directly (cytokine mediated)



      • •

        Patients will have warm edematous extremities and varying degrees of pulmonary edema



    • •

      Hypovolemic shock with preexisting heart failure occurs most commonly when an individual with chronic decompensated heart failure develops hemorrhagic shock or (less commonly) third-spacing physiology



      • •

        Hypovolemic shock causes low CVP, RVEDP, and LVEDP physiology such that:



        • •

          Individuals with preexisting volume overload will have mobilized (resolved) all of their pulmonary edema by the time their hypovolemic disease process (eg, GI bleeding) causes shock


        • •

          Long-standing lower extremity edema, however, may persist and be present at presentation in these individuals because this fluid may be slower to mobilize



      • •

        Volume depletion and heart failure cannot coexist



        • •

          Volume depletion is a low total-body sodium content state


        • •

          Heart failure is a volume-overloaded, high total body sodium content state





Sep 14, 2018 | Posted by in RESPIRATORY | Comments Off on Shock

Full access? Get Clinical Tree

Get Clinical Tree app for offline access